SkinBioTherapeutics plc (AIM:SBTX)
London · Delayed Price · Currency is GBP · Price in GBX 15.75
-0.10 (-0.63%)
Dec 31, 2025, 11:21 AM GMT+1
SkinBioTherapeutics Market Cap
SkinBioTherapeutics has a market cap or net worth of 40.76 million as of December 31, 2025. Its market cap has decreased by -6.09% in one year.
Market Cap
40.76M
Enterprise Value
36.97M
Revenue
4.64M
Ranking
n/a
PE Ratio
n/a
Stock Price
15.75
Market Cap Chart
Since April 5, 2017, SkinBioTherapeutics's market cap has increased from 15.73M to 40.76M, an increase of 159.13%. That is a compound annual growth rate of 11.50%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 31, 2025 | 40.76M | -3.56% |
| Dec 31, 2024 | 42.26M | 45.57% |
| Dec 29, 2023 | 29.03M | 8.17% |
| Dec 30, 2022 | 26.84M | -59.24% |
| Dec 31, 2021 | 65.85M | 79.74% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Apr 5, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 213.85B |
| GSK plc | 73.21B |
| Haleon | 33.38B |
| Smith & Nephew | 10.52B |
| Convatec Group | 4.74B |
| Hikma Pharmaceuticals | 3.43B |
| HUTCHMED (China) | 1.79B |
| Genus | 1.74B |